Nicholas Bradford Johnson, - Medicare Plastic And Reconstructive Surgery in Idaho Falls, ID

Nicholas Bradford Johnson, is a medicare enrolled "Surgery - Plastic And Reconstructive Surgery" physician in Idaho Falls, Idaho. He went to St. Louis College Of Physicians And Surgeons and graduated in 2010 and has 14 years of diverse experience with area of expertise as Plastic And Reconstructive Surgery. He is a member of the group practice Idaho Physician Services Inc and his current practice location is 3200 Channing Way Ste 206, Idaho Falls, Idaho. You can reach out to his office (for appointments etc.) via phone at (208) 529-2230.

Nicholas Bradford Johnson is licensed to practice in Idaho (license number M-14721) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1578850210.

Contact Information

Nicholas Bradford Johnson,
3200 Channing Way Ste 206,
Idaho Falls, ID 83404-7546
(208) 529-2230
(208) 453-6142



Physician's Profile

Full NameNicholas Bradford Johnson
GenderMale
SpecialityPlastic And Reconstructive Surgery
Experience14 Years
Location3200 Channing Way Ste 206, Idaho Falls, Idaho
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Nicholas Bradford Johnson attended and graduated from St. Louis College Of Physicians And Surgeons in 2010
  NPI Data:
  • NPI Number: 1578850210
  • Provider Enumeration Date: 07/01/2011
  • Last Update Date: 02/28/2024
  Medicare PECOS Information:
  • PECOS PAC ID: 2860783404
  • Enrollment ID: I20190927000381

Medical Identifiers

Medical identifiers for Nicholas Bradford Johnson such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1578850210NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208200000XPlastic Surgery M-14721 (Idaho)Secondary
208200000XPlastic Surgery 83999 (Georgia)Secondary
208200000XPlastic Surgery 01076429A (Indiana)Secondary
2086S0122XSurgery - Plastic And Reconstructive Surgery M-14721 (Idaho)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Eastern Idaho Regional Medical CenterIdaho falls, IDHospital
Mountain View HospitalIdaho falls, IDHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Idaho Physician Services Inc216343094328

News Archive

AGA Medical Holdings receives regulatory product approvals and licenses in China

AGA Medical Holdings, Inc. (AGA Medical) has received regulatory approvals and licenses in China for its AMPLATZER® PFO Occluder and AMPLATZER® Multi-Fenestrated Septal Occluder "Cribriform."

Water overdose proves to be a killer

A British man who drank 17 pints of cold water in eight hours, five times the recommended daily amount, in order to relieve a painful gum condition has died as a result.

Verma unveils state Medicaid scorecard but refuses to judge efforts

The Trump administration Monday released a Medicaid "scorecard" intended to show how the nation's largest health program is performing. But the nation's top Medicaid official didn't want to draw any conclusions.

New patent to develop antibody therapies for cancer and other diseases

The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.

Cancer Vaccine - Synthetically generated glycopeptides from tumor cells can stimulate the formation of specific antibodies

Tumor cells and healthy somatic cells differ in the structures on their surfaces. In principle, it should thus be possible to develop a vaccine that causes a patient's immune system to form antibodies that attack and destroy tumor cells while sparing healthy cells.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Nicholas Bradford Johnson allows following entities to bill medicare on his behalf.
Entity NameIdaho Physician Services Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1902841893
PECOS PAC ID: 2163430943
Enrollment ID: O20070208000680

News Archive

AGA Medical Holdings receives regulatory product approvals and licenses in China

AGA Medical Holdings, Inc. (AGA Medical) has received regulatory approvals and licenses in China for its AMPLATZER® PFO Occluder and AMPLATZER® Multi-Fenestrated Septal Occluder "Cribriform."

Water overdose proves to be a killer

A British man who drank 17 pints of cold water in eight hours, five times the recommended daily amount, in order to relieve a painful gum condition has died as a result.

Verma unveils state Medicaid scorecard but refuses to judge efforts

The Trump administration Monday released a Medicaid "scorecard" intended to show how the nation's largest health program is performing. But the nation's top Medicaid official didn't want to draw any conclusions.

New patent to develop antibody therapies for cancer and other diseases

The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.

Cancer Vaccine - Synthetically generated glycopeptides from tumor cells can stimulate the formation of specific antibodies

Tumor cells and healthy somatic cells differ in the structures on their surfaces. In principle, it should thus be possible to develop a vaccine that causes a patient's immune system to form antibodies that attack and destroy tumor cells while sparing healthy cells.

Read more Medical News

› Verified 6 days ago

Entity NameSteele Lake Specialty Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1215716998
PECOS PAC ID: 1153774567
Enrollment ID: O20240201000040

News Archive

AGA Medical Holdings receives regulatory product approvals and licenses in China

AGA Medical Holdings, Inc. (AGA Medical) has received regulatory approvals and licenses in China for its AMPLATZER® PFO Occluder and AMPLATZER® Multi-Fenestrated Septal Occluder "Cribriform."

Water overdose proves to be a killer

A British man who drank 17 pints of cold water in eight hours, five times the recommended daily amount, in order to relieve a painful gum condition has died as a result.

Verma unveils state Medicaid scorecard but refuses to judge efforts

The Trump administration Monday released a Medicaid "scorecard" intended to show how the nation's largest health program is performing. But the nation's top Medicaid official didn't want to draw any conclusions.

New patent to develop antibody therapies for cancer and other diseases

The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.

Cancer Vaccine - Synthetically generated glycopeptides from tumor cells can stimulate the formation of specific antibodies

Tumor cells and healthy somatic cells differ in the structures on their surfaces. In principle, it should thus be possible to develop a vaccine that causes a patient's immune system to form antibodies that attack and destroy tumor cells while sparing healthy cells.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Nicholas Bradford Johnson is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Nicholas Bradford Johnson,
Po Box 277381,
Atlanta, GA 30384-7381

Ph: (208) 529-2230
Nicholas Bradford Johnson,
3200 Channing Way Ste 206,
Idaho Falls, ID 83404-7546

Ph: (208) 529-2230

News Archive

AGA Medical Holdings receives regulatory product approvals and licenses in China

AGA Medical Holdings, Inc. (AGA Medical) has received regulatory approvals and licenses in China for its AMPLATZER® PFO Occluder and AMPLATZER® Multi-Fenestrated Septal Occluder "Cribriform."

Water overdose proves to be a killer

A British man who drank 17 pints of cold water in eight hours, five times the recommended daily amount, in order to relieve a painful gum condition has died as a result.

Verma unveils state Medicaid scorecard but refuses to judge efforts

The Trump administration Monday released a Medicaid "scorecard" intended to show how the nation's largest health program is performing. But the nation's top Medicaid official didn't want to draw any conclusions.

New patent to develop antibody therapies for cancer and other diseases

The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.

Cancer Vaccine - Synthetically generated glycopeptides from tumor cells can stimulate the formation of specific antibodies

Tumor cells and healthy somatic cells differ in the structures on their surfaces. In principle, it should thus be possible to develop a vaccine that causes a patient's immune system to form antibodies that attack and destroy tumor cells while sparing healthy cells.

Read more News

› Verified 6 days ago


Surgery Doctors in Idaho Falls, ID

Warren E Albrecht, DO
Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 2985 Cortez Ave Ste 200, Idaho Falls, ID 83404
Phone: 208-528-1000    Fax: 208-528-1900
Brad D Smith, D.O.
Surgery
Medicare: Medicare Enrolled
Practice Location: 2805 Valencia Dr, Idaho Falls, ID 83404
Phone: 208-552-3184    Fax: 208-525-6151
Dr. Gregory R. Hodson, M.D.
Surgery
Medicare: Not Enrolled in Medicare
Practice Location: 2225 Teton Plz, Ste B, Idaho Falls, ID 83404
Phone: 208-524-4660    Fax: 208-524-4617
Dr. John Garth Oliver Miller, M.D.
Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 2327 Coronado St Fl 2, Idaho Falls, ID 83404
Phone: 208-528-1750    
Dr. Michael Kirk Moore Jr., M.D., P.C.
Surgery
Medicare: Not Enrolled in Medicare
Practice Location: 2860 Channing Way, Suite 213, Idaho Falls, ID 83404
Phone: 208-552-1406    Fax: 208-552-1416
Bruce James Watkins, M.D.
Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 3369 Merlin Dr Ste B, Idaho Falls, ID 83404
Phone: 844-919-4263    Fax: 833-513-0980
Adam Meziani, M.D.
Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 3200 Channing Way Ste 206, Idaho Falls, ID 83404
Phone: 208-529-2230    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.